In line with our previous results in esophageal cancer cells, the treatment of prostate cancer cells with STL001 in combination with taxol enhanced the cytotoxic effects of taxol therapy, detected by induction of strong apoptotic cell death indicated by caspase-3 cleavage (Fig. 6C). Here, CASP3 is linked to esophageal cancer.